Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis

References

• Bruck K, Jager KJ, Dounousi E, et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant. 2016;31(4):680.
   PubMed Web of Science ®Google Scholar
• Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet. 2014;2(3):e174–81.
   PubMed Web of Science ®Google Scholar
• Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957.
   PubMed Web of Science ®Google Scholar
• Bellorin-Font E, Vasquez-Rios G, Martin KJ. Controversies in the management of secondary hyperparathyroidism in chronic kidney disease. Curr Osteoporos Rep. 2019;17(5):333–342.
   PubMed Web of Science ®Google Scholar
• Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119–1127.
   PubMed Web of Science ®Google Scholar
• Kahan S, Manson JE. Nutrition counseling in clinical practice: how clinicians can do better. JAMA. 2017;318(12):1101–1102.
   PubMed Web of Science ®Google Scholar
• Bump M. Organic phosphorus versus inorganic phosphorus: empowering adult kidney patients with nutrition education. J Ren Nutr. 2016;26(5):e31–3.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Rodriguez-Ortiz ME. Advances in pharmacotherapy for secondary hyperparathyroidism. Expert Opin Pharmacother. 2015;16(11):1703–1716.
   PubMed Web of Science ®Google Scholar
• Rroji M, Spasovski G. Calcimimetics versus parathyroidectomy: what is preferable? Int Urol Nephrol. 2018;50(7):1271–1275.
   PubMed Web of Science ®Google Scholar
• Ivarsson KM, Akaberi S, Isaksson E, et al. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant. 2015;30(12):2027–2033.
   PubMed Web of Science ®Google Scholar
• Eidman KE, Wetmore JB. The role of parathyroidectomy in the management of secondary hyperparathyroidism. Curr Opin Nephrol Hypertens. 2017;26(6):516–522.
   PubMed Web of Science ®Google Scholar
• Kuczera P, Adamczak M, Więcek A. Safety and efficiency of treatment with cinacalcet of haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism. Endokrynologia Polska. 2013;64(3):176–181.
   PubMed Web of Science ®Google Scholar
• Toussaint ND, Damasiewicz MJ. Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms? Nephrology. 2017;22(Suppl 2):51–56.
   PubMed Web of Science ®Google Scholar
• Xu L, Wan X, Huang Z, et al. Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PloS One. 2013;8(4):e61387.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhang X, Lu Y, et al. Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Sci Rep. 2018; 8(1):7743.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Nour-Eldin NA, Albrecht MH, et al. Thermal ablation of lung tumors: focus on microwave ablation. Rofo. 2017;189(9):828–843.
   PubMedGoogle Scholar
• Vogl TJ, Nour-Eldin NA, Hammerstingl RM, et al. Microwave ablation (mwa): basics, technique and results in primary and metastatic liver neoplasms. Rofo. 2017; 89(11):1055–1066.
   Google Scholar
• Dou JP, Liang P, Yu J. Microwave ablation for liver tumors. Abdom Radiol. 2016;41(4):650–658.
   PubMed Web of Science ®Google Scholar
• Miller JJ. The inverse of the freeman – Tukey double arcsine transformation. Am Stat. 1978;32(4):138–138.
   Web of Science ®Google Scholar
• Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Statist. 1950;21(4):607–611.
   Google Scholar
• Borenstein MH, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester, West Sussex: John Wiley & Sons, Ltd; 2009.
   Google Scholar
• Sutton AA, Jones DR, Sheldon TA, et al. Methods for meta‐analysis in medical research. Chichester, West Sussex: John Wiley & Sons, Ltd;. 2000.
   Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med. 2006;25(20):3443–3457.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Diao ZL, Liu X, Qian LX, et al. Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthe. 2016;32(6):614–622.
   PubMed Web of Science ®Google Scholar
• Jiang BH, Wang XY, Yao ZY, et al. Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients. Hemodial Int. 2019;23(2):247–253.
   PubMed Web of Science ®Google Scholar
• Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperther. 2016;32(2):180–186.
   PubMed Web of Science ®Google Scholar
• Zhao J, Qian L, Zu Y, et al. Efficacy of ablation therapy for secondary hyperparathyroidism by ultrasound guided percutaneous thermoablation. Ultrasound Med Biol. 2016; 42(5):1058–1065.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng L-L, Zhang Y-M, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282(2):576–584.
   PubMed Web of Science ®Google Scholar
• Li X, An C, Yu MA, et al. US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study. Int J Hyperther. 2019;36(1):321–327.
   Web of Science ®Google Scholar
• Li X, Wei Y, Shao HZ, et al. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study. Int J Hyperther. 2019;36(1):646–653.
   Web of Science ®Google Scholar
• Zhuo L, Zhang L, Peng L-L, et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection. Int J Hyperther.. 2019;36(1):29–35.
   PubMed Web of Science ®Google Scholar
• Isakova T, Nickolas TL, Denburg M, et al. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737–751.
   PubMed Web of Science ®Google Scholar
• Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–918.
   PubMed Web of Science ®Google Scholar
• Lang BH, Woo YC, Wong C. High-intensity focused ultrasound for treatment of symptomatic benign thyroid nodules: a prospective study. Radiology. 2017;284(3):897–906.
   PubMed Web of Science ®Google Scholar
• Teng D, Ding L, Wang Y, et al. Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study. Endocrine. 2018;62(3):648–654.
   PubMed Web of Science ®Google Scholar
• Wan J, Li W, Zhong Y. Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism. J Clin Lab Anal. 2019;33(3):e22696.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu Y, Feng S, et al. Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Renal Failure. 2019;41(1):921–929.
   PubMed Web of Science ®Google Scholar
• Montenegro J, Cornago I, Gallardo I, et al. Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis. Nephrology. 2012;17(1):26–31.
   PubMed Web of Science ®Google Scholar
• Gong L, Tang W, Lu J, et al. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg. 2019;70:13–18.
   PubMed Web of Science ®Google Scholar
• Tominaga Y, Kakuta T, Yasunaga C, et al. Evaluation of parathyroidectomy for secondary and tertiary hyperparathyroidism by the Parathyroid Surgeons’ Society of Japan. Ther Apher Dial. 2016; 20(1):6–11.
   PubMed Web of Science ®Google Scholar